PL2585445T3 - Polimorfy aktywnego składnika farmaceutycznego - Google Patents
Polimorfy aktywnego składnika farmaceutycznegoInfo
- Publication number
- PL2585445T3 PL2585445T3 PL11727454T PL11727454T PL2585445T3 PL 2585445 T3 PL2585445 T3 PL 2585445T3 PL 11727454 T PL11727454 T PL 11727454T PL 11727454 T PL11727454 T PL 11727454T PL 2585445 T3 PL2585445 T3 PL 2585445T3
- Authority
- PL
- Poland
- Prior art keywords
- polymorphs
- active pharmaceutical
- pharmaceutical ingredient
- ingredient
- active
- Prior art date
Links
- 239000008186 active pharmaceutical agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10167344.0A EP2399911B1 (en) | 2010-06-25 | 2010-06-25 | Polymorphs of Febuxostat |
| EP11727454.8A EP2585445B1 (en) | 2010-06-25 | 2011-06-24 | Polymorphs of an active pharmaceutical ingredient |
| PCT/EP2011/060630 WO2011161245A2 (en) | 2010-06-25 | 2011-06-24 | Polymorphs of an active pharmaceutical ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2585445T3 true PL2585445T3 (pl) | 2016-01-29 |
Family
ID=43033242
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10167344T PL2399911T3 (pl) | 2010-06-25 | 2010-06-25 | Polimorfy febuksostatu |
| PL11727454T PL2585445T3 (pl) | 2010-06-25 | 2011-06-24 | Polimorfy aktywnego składnika farmaceutycznego |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10167344T PL2399911T3 (pl) | 2010-06-25 | 2010-06-25 | Polimorfy febuksostatu |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8946441B2 (pl) |
| EP (3) | EP2399911B1 (pl) |
| CA (1) | CA2802937C (pl) |
| DK (2) | DK2399911T3 (pl) |
| ES (2) | ES2553584T3 (pl) |
| PL (2) | PL2399911T3 (pl) |
| WO (1) | WO2011161245A2 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2399911T3 (en) * | 2010-06-25 | 2015-09-07 | Sandoz Ag | Polymorphs of Febuxostat. |
| CN103396378B (zh) * | 2013-07-29 | 2015-06-10 | 杭州朱养心药业有限公司 | 非布司他结晶 |
| CZ27857U1 (cs) | 2014-12-12 | 2015-02-23 | Zentiva, K.S. | Formulace obsahující tuhý roztok febuxostatu |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1275126A (zh) | 1998-06-19 | 2000-11-29 | 帝人株式会社 | 2－(3－氰基－4－异丁氧基苯基)－4－甲基－5－噻唑甲酸的多晶型体及其制备方法 |
| SI1488790T1 (sl) | 2002-03-28 | 2014-09-30 | Teijin Pharma Limited | Trden pripravek, ki vsebuje eno samo kristalno a-obliko derivata tiazolkarboksilne kisline |
| KR101310002B1 (ko) | 2009-06-10 | 2013-09-25 | 테바 파마슈티컬 인더스트리즈 리미티드 | 페북소스타트의 결정형 |
| CN101648926B (zh) * | 2009-07-09 | 2011-11-16 | 石药集团欧意药业有限公司 | 一种非布司他晶型及其制备方法 |
| CN101817801A (zh) | 2009-08-12 | 2010-09-01 | 北京红惠新医药科技有限公司 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸新晶型k及其他晶型的制备方法 |
| DK2399911T3 (en) | 2010-06-25 | 2015-09-07 | Sandoz Ag | Polymorphs of Febuxostat. |
-
2010
- 2010-06-25 DK DK10167344.0T patent/DK2399911T3/en active
- 2010-06-25 ES ES10167344.0T patent/ES2553584T3/es active Active
- 2010-06-25 EP EP10167344.0A patent/EP2399911B1/en not_active Revoked
- 2010-06-25 PL PL10167344T patent/PL2399911T3/pl unknown
-
2011
- 2011-06-24 PL PL11727454T patent/PL2585445T3/pl unknown
- 2011-06-24 EP EP11727454.8A patent/EP2585445B1/en not_active Revoked
- 2011-06-24 WO PCT/EP2011/060630 patent/WO2011161245A2/en not_active Ceased
- 2011-06-24 ES ES11727454.8T patent/ES2553574T3/es active Active
- 2011-06-24 US US13/702,077 patent/US8946441B2/en active Active
- 2011-06-24 CA CA2802937A patent/CA2802937C/en not_active Expired - Fee Related
- 2011-06-24 EP EP15181097.5A patent/EP2977372B1/en not_active Revoked
- 2011-06-24 DK DK11727454.8T patent/DK2585445T3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2977372A1 (en) | 2016-01-27 |
| ES2553584T3 (es) | 2015-12-10 |
| CA2802937A1 (en) | 2011-12-29 |
| DK2399911T3 (en) | 2015-09-07 |
| EP2399911A1 (en) | 2011-12-28 |
| US20130137734A1 (en) | 2013-05-30 |
| WO2011161245A3 (en) | 2012-03-08 |
| EP2977372B1 (en) | 2019-05-08 |
| ES2553574T3 (es) | 2015-12-10 |
| EP2585445A2 (en) | 2013-05-01 |
| PL2399911T3 (pl) | 2016-01-29 |
| US8946441B2 (en) | 2015-02-03 |
| CA2802937C (en) | 2020-02-25 |
| EP2585445B1 (en) | 2015-08-19 |
| DK2585445T3 (en) | 2015-09-07 |
| WO2011161245A2 (en) | 2011-12-29 |
| EP2399911B1 (en) | 2015-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201306237B (en) | Solid forms of a pharmaceutically active substance | |
| IL238713A0 (en) | Self-regulating active pharmaceutical ingredient release | |
| PL2560624T3 (pl) | Formulacja terapeutyczna do zmniejszania skutków ubocznych leku | |
| EP2549986A4 (en) | MACROPHONE LEAVE TO MULTIPLE OBJECTIVES | |
| GB2486567B (en) | Pharmaceutical formulation | |
| IL232305B (en) | Pharmacy preparations | |
| EP2599484A4 (en) | INJECTABLE PHARMACEUTICAL PREPARATION OF MELPHALANE | |
| PL2585041T3 (pl) | Preparat farmaceutyczny o zamaskowanym smaku o przyspieszonym początku działania | |
| IL236465A0 (en) | Pharmaceutical composition for delayed release of active substances | |
| PL2536412T3 (pl) | Wziewna kompozycja farmaceutyczna | |
| IL224192A (en) | Compositions of Vitamin 14 – Epi Analogs d | |
| PL2585445T3 (pl) | Polimorfy aktywnego składnika farmaceutycznego | |
| ZA201300083B (en) | New drug combinations for the treatment of malaria | |
| SI2474529T1 (sl) | Kristalne oblike aktivne farmacevtske učinkovine | |
| HUE063546T2 (hu) | Monolitikus gyógyászati forma egy hatóanyagkombináció módosított leadására | |
| HU1000444D0 (en) | Process for the preparation of a pharmaceutical active ingredient | |
| EP2543373A4 (en) | PHARMACEUTICAL COMPOSITION OF LEVOAMLODIPINE COMPOUND | |
| GB201001203D0 (en) | Use of pharmaceutically active compounds | |
| GB201314772D0 (en) | Pharmaceutical compositons of immunosuppressants | |
| EP2536688A4 (en) | STABLE DOSAGE FORMS OF LEVOMILNACIPRAN | |
| PL2407159T3 (pl) | Kompozycje farmaceutyczne olmesartanu | |
| GB201012047D0 (en) | Pharmaceutical formulations | |
| GB201012046D0 (en) | Pharmaceutical formulations | |
| HUP1000429A2 (en) | Basic salts of a pharmaceutical active ingredient | |
| PL390620A1 (pl) | Preparat farmaceutyczny |